Trials / Completed
CompletedNCT03374306
Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate
Treatment Effect of Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate as Classified by Electro-retinal Responses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- The Hong Kong Polytechnic University · Academic / Other
- Sex
- All
- Age
- 7 Years – 10 Years
- Healthy volunteers
- Accepted
Summary
Our project is a 24-month longitudinal randomized controlled trial that aims to investigate the myopia development after topical application of 0.01% atropine in children with either fast or slow myopia progression classified according to their initial electro-retinal responses. This will help elucidate the effectiveness of using low concentration atropine for myopia control in children with different myopia progression rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atropine (0.01%) | tropical application |
| DRUG | Artificial tear | tropical application |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2019-12-31
- Completion
- 2020-08-31
- First posted
- 2017-12-15
- Last updated
- 2024-10-16
- Results posted
- 2024-10-16
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT03374306. Inclusion in this directory is not an endorsement.